Elanco
Colleen Dekker is an experienced communications professional currently serving as Executive Director of Global Corporate Communications at Elanco since November 2010, where responsibilities include leading internal, external, and executive communications, with expertise in merger and acquisition communications, notably for Novartis Animal Health. Prior to Elanco, Colleen Dekker spent over a decade at FleishmanHillard, where roles included Partner and Senior Vice President, managing strategic communications for clients in agriculture and food industries. Early in the career, Colleen Dekker worked at Bader Rutter and Associates as a Writer. Colleen Dekker holds a degree from the University of Illinois Urbana-Champaign, obtained in 1996.
Elanco
26 followers
Elanco Animal Health Incorporated is an animal health company that develops, manufactures and markets products for companion and food animals. The Company offers its products under four primary categories, such as Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine.